ALNY vs MNTN · P/E 76, rev $1.29B vs rev $290.1M
Alnylam Pharmaceuticals Inc (ALNY) versus MNTN, Inc. (MNTN) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
MNTN, Inc. (MNTN) is a software - application company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported MNTN revenue for 2025-12-31 was $290.1M. Net income was -$6.4M. Revenue was up 28.6% from 2024-12-31 to 2025-12-31. MNTN currently screens at market cap $0.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. MNTN currently screens at market cap $0.
Not investment advice. Open the ALNY and MNTN stock pages for the full models.
Not investment advice.